Founder & CEO
Elise completed a Bachelor of Science in Mechanical Engineering and a Masters of Biomedical Engineering with Business at The University of Melbourne in 2017. Elise has previous work experience working in some small to large corporate businesses in the healthcare sector. Elise is a strong leader and an innovative and strategic thinker who has successfully taken Stelect into a venture backed business creating impactful technical innovation with a large-scale commercial impact. Elise was an honouree of Forbes 30 Under 30 Asia for 2020.
Lead Sensor Design Engineer
Anurupa received her Bachelor of Technology degree in Mechanical Engineering in 2011 from National Institute of Technology, Durgapur, India. She completed her Master in Science degree from Georgia Institute of Technology, USA (France Campus), in 2014, and her PhD at FEMTO-ST, France, in Engineering Sciences and Micro-techniques in 2017. She has a background in acoustics, and has experience in micro and nano fabrication, and transducer design. Her research interests include ultrasonics, acousto-optics, elastic-wave propagation, piezoelectric materials, non- destructive testing and evaluation, characterization of micro-systems and nano-structures, SAW and BAW devices, and printed electronics.
DR ANDREW AJANI
Clinical Advisor to the Board
Andrew is an experienced Interventional Cardiologist and is the current director of Melbourne Interventional Group. Andrew is active in cardiology education, holding associate Professorships at The University of Melbourne and Monash University. Andrew was the lead clinician in interventional cardiology startup, IntelliMedical Technologies which developed a steerable guide wire. IntelliMedical was acquired by Merit Medical in 2018.
Anna is an experienced Intellectual Property Lawyer with further expertise is corporate governance, corporate law and legal negotiations. Anna is the group general manager of Risk and Legal at Programmed as well as being the President (Victorian Division) and NonExecutive Director of the Association of Corporate Counsel Australia. Anna has previous experience as a lawyer for both Baker and Mckenzie and Corrs Chambers Westgarth.
Matt is an experienced executive in medical device commercialisation who has successfully brought many cardiac devices to market. Matt was previously the Managing Director of Merit Medical, a leading manufacturer and marketer of disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Previous to this role, Matt has experience working for medical device companies including Abbott Vascular, Biosense Webster, St Jude and Medtronic.
Chris is an experienced executive with strong leadership, board, management and operational experience. He has developed a strategy and successfully built a business that is one of the leading services companies in Australia and New Zealand. With an engineering / analytical background, Chris is a strong strategic thinker who has significant first-hand experience with major corporate activity, financing, M & A and capital raising.
Artesian Investment, an Australian Venture Capital Firm, invested in Stelect in August 2018, October 2018 and in May 2019.
Stelect's novel medical device is aimed at increasing the accuracy rate in coronary stent selection. The Stelect Tech utilises ultrasound technology in order to assist clinicians with the evaluation of coronary artery blockages.
Learn more about our the Stelect Tech by clicking the button below.